Suppr超能文献

IRF-1肿瘤抑制因子实现最大程度的生长抑制需要一个新的阻遏结构域。

A novel repressor domain is required for maximal growth inhibition by the IRF-1 tumor suppressor.

作者信息

Eckert Mirjam, Meek Sarah E M, Ball Kathryn L

机构信息

Cancer Research UK (CRUK) Interferon and Cell Signalling Group, Cell Signalling Unit, The University of Edinburgh Cancer Research Centre, Edinburgh EH4 2XR, United Kingdom.

出版信息

J Biol Chem. 2006 Aug 11;281(32):23092-102. doi: 10.1074/jbc.M512589200. Epub 2006 May 4.

Abstract

Interferon regulatory factor-1 (IRF-1) is a transcription factor and tumor suppressor that can regulate gene expression in a manner requiring either its sequence specific DNA binding activity or its ability to bind the p300 coactivator. We show that IRF-1-mediated growth inhibition is dependent on the integrity of a C-terminal transcriptional enhancer domain. An enhancer subdomain (amino acids 301-325) that differentially regulates IRF-1 activity has been identified and this region mediates the repression of Cdk2. The repressor domain encompasses an LXXLL coregulator signature motif and mutations or deletions within this region completely uncouple transcriptional activation from repression. The loss of growth suppressor activity when the Cdk2-repressor domain of IRF-1 is mutated implicates repression as a determinant of its maximal growth inhibitory potential. The data link IRF-1 regulatory domains to its growth inhibitory activity and provide information about how differential gene regulation may contribute to IRF-1 tumor suppressor activity.

摘要

干扰素调节因子-1(IRF-1)是一种转录因子和肿瘤抑制因子,它可以通过需要其序列特异性DNA结合活性或结合p300共激活因子的能力的方式来调节基因表达。我们发现,IRF-1介导的生长抑制依赖于C末端转录增强子结构域的完整性。已鉴定出一个差异调节IRF-1活性的增强子亚结构域(氨基酸301-325),该区域介导对Cdk2的抑制。抑制结构域包含一个LXXLL共调节因子特征基序,该区域内的突变或缺失完全消除了转录激活与抑制之间的联系。当IRF-1的Cdk2抑制结构域发生突变时,生长抑制活性丧失,这表明抑制是其最大生长抑制潜力的决定因素。这些数据将IRF-调节结构域与其生长抑制活性联系起来,并提供了关于差异基因调节如何可能有助于IRF-1肿瘤抑制活性的信息。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验